Quality of life assessment during six months of NSAID treatment [Gonarthrosis and quality of life (GOAL) study]

Clinical and Experimental Rheumatology

Volumn 16, Issue 1, 1998, Pages 49-54

  La Montagna, G ^a   Tirri, G ^a   Cacace, E ^b   Perpignano, G ^b   Covelli, M ^c   Pipitone, V ^c   D'Agostino, P ^d   Magaro M ^d   Ferraccioli, G ^e   Mascia, M T ^f   Manzini, E ^f   Minari, C ^g   Barreca, C ^g   Marcolongo, R ^g   Paresce, E ^h   Colombo, B ^h  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c POLICLINICO   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF UDINE   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g UNIVERSITY OF SIENA   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

Author keywords

Gonarthrosis; Long term treatment; NSAIDs; Quality of life

Indexed keywords

DICLOFENAC; PIROXICAM BETA CYCLODEXTRIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; CYCLODEXTRINS; DICLOFENAC; DRUG COMBINATIONS; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS; PATIENT COMPLIANCE; PATIENT DROPOUTS; PIROXICAM; QUALITY OF LIFE;

EID: 0031892112     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. DIEPPE P: Management of pain in osteoarthritis: Current approaches. Drugs 1996; 52 (Suppl. 3): 1-62.
2. CUNNINGHAM LS, KELSEY JL: Epidemiology of musculoskeletal impairments and associated disability. Am J Public Health 1984; 74: 574-9.
3. HADIER NM: Osteoarthritis as a public health problem. Clin Rheum Dis 1985; 11: 175-85.
4. TENNANT A, FEAR J, PICKERING A, HILLMAN M, CUTTS A, CHAMBERLAIN MA: Prevalence of knee problems in the population aged 55 years and over: Identifying the need for knee arthroplasty. Br Med J 1995; 310: 1291-3.
5. BRADLEY JD, BRANDT KD, KATZ BP, KALASINSKI LA, RYAN SI: Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325: 87-91.
6. DIEPPE P, CUSHNAHAN J, JASANI MK, MCRAE F, WATT I: A two year, placebo controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br J Rheumatol 1993; 32: 595-600.
7. FRIES JF, WILLIAMS CA, BLOCH DA: The relative toxicity of nonsteroidal anti-inflammatory drugs. Arthritis Rheum 1991; 434: 1353-60.
8. SOMMERVILLE K, FAULKNER G, LANGMAN MJS: Nonsteroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; i: 462-4.
9. FRIES JJ, SPITZ P, KRAINES RG, HOLMAN HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
10. RANZA R, MARCHESONI A, CALORI G et al.: The Italian version of the functional disability index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol 1993; 11: 1238.
11. SALAFFI F, CAVALIERI F, NOLLI M, FERRACCIOLI GF: Analysis of disability in knee osteoarthritis. Relationship with age and psychological variables but not with the radiographic score. J Rheumatol 1991; 18: 1581-5.
12. CAVALIERI F, SALAFFI F, NOLLI M, FERRACCIOLI GF: Relationship between the physical impairment, psychological variables and pain in rheumatoid arthritis. Analysis of their relative impact. Clin Exp Rheumatol 1991; 9: 47-50.
13. SCOTT PJ, ANSELL BM, HUSKISSON EC: Measurement of pain in juvenile chronic polyarthritis. Ann Rheum Dis 1977; 36: 186-7.
14. NOLLI M, GHIRELLI L, FERRACCIOLI GF: Pain language in fibromyalgia, rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 1988; 6: 27-31.
15. ALTMAN R, ASCH E, BLOCH D et al: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
16. KELLGREN JF, LAWRENCE JS: Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957; 16: 494-9.
17. WILLET LR, CARSON JL, STROM BL: Epidemiology of gastrointestinal damage associated with nonsteroidal antiinflammatory drugs. Drug Safety 1994; 10: 170-81.
18. DIEPPE P, CUSHNAGHAN J: The natural course and prognosis of osteoarthritis. In MOSKOWITS RW et al. (Eds.): Osteoarthritis: Diagnosis and Medical Surgical Management. Philadelphia, W.B. Saunders Co., 1992; 399-412.
19. REVELL PA, MAYSTON V, LALOR P, MAPP P: The synovial membrane in osteoarthritis: A histological study including the characterization of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis 1988; 47: 300-307.
20. DEAN DD, MARTEL-PELLETIER J, PELLIETER JP, HOWELL DS, WOESSNER JF Jr.: Evidence for metalloproteinasc and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989; 84: 678-5.
21. VAN DER KRAAN PM, VITTERS EL, VAN DE PUTTE LBA, VAN DEN BERG WB: Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joint. Am J Pathol 1989; 135: 1001-14.
22. PINALS RS: Mechanisms of joint destruction, pain and disability in osteoarthritis. Drugs 1996; 52: 14-20.
23. WARD DE, VEYS EM, BOWDIER JM, ROMA J: Comparison of aceciofenac with diciofenac in the treatment of osteoarthritis. Clin Rheumatol 1995; 14: 656-62.
24. HUSKISSON EC, BERRY H, GISHEN P, JUBB RW, and WITHEHEAD J (on behalf of the LINK STUDY GROUP): Effects of anti-inflammatory drugs on the progression of osteoarthritis of the knee. J Rheumatol 1995; 22: 1941-6.